Medicis Pharmaceutical (MRX) Competitors

Medicis Pharmaceutical (NYSE:MRX) and Cboe Global Markets (NASDAQ:CBOE) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Is MRX or CBOE a better dividend stock?

Medicis Pharmaceutical pays an annual dividend of $0.56 per share and has a dividend yield of 1.5%. Cboe Global Markets pays an annual dividend of $2.52 per share and has a dividend yield of 1.1%. Cboe Global Markets pays out 33.0% of its earnings in the form of a dividend. Cboe Global Markets has increased its dividend for 1 consecutive years.

Does the media favor MRX or CBOE?

In the previous week, Cboe Global Markets had 14 more articles in the media than Medicis Pharmaceutical. MarketBeat recorded 15 mentions for Cboe Global Markets and 1 mentions for Medicis Pharmaceutical. Cboe Global Markets' average media sentiment score of 1.49 beat Medicis Pharmaceutical's score of 0.00 indicating that Cboe Global Markets is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medicis Pharmaceutical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cboe Global Markets	13 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MRX or CBOE more profitable?

Cboe Global Markets has a net margin of 18.64% compared to Medicis Pharmaceutical's net margin of 0.00%. Cboe Global Markets' return on equity of 22.02% beat Medicis Pharmaceutical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medicis Pharmaceutical	N/A	N/A	N/A
Cboe Global Markets	18.64%	22.02%	10.73%

Which has stronger earnings & valuation, MRX or CBOE?

Cboe Global Markets has higher revenue and earnings than Medicis Pharmaceutical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicis Pharmaceutical	$1.24B	2.18	$141.30M	N/A	N/A
Cboe Global Markets	$4.09B	6.02	$764.90M	$7.63	30.83

Do insiders and institutionals hold more shares of MRX or CBOE?

82.7% of Cboe Global Markets shares are owned by institutional investors. 3.8% of Medicis Pharmaceutical shares are owned by company insiders. Comparatively, 0.2% of Cboe Global Markets shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Do analysts recommend MRX or CBOE?

Medicis Pharmaceutical presently has a consensus price target of $44.00, indicating a potential upside of 14.14%. Cboe Global Markets has a consensus price target of $219.64, indicating a potential downside of 6.63%. Given Medicis Pharmaceutical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Medicis Pharmaceutical is more favorable than Cboe Global Markets.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicis Pharmaceutical	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Cboe Global Markets	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Summary

Cboe Global Markets beats Medicis Pharmaceutical on 10 of the 16 factors compared between the two stocks.